SOP Guide for Pharma

Analytical Method Development: Aseptic Technique SOP for AMD – V 2.0

Analytical Method Development: Aseptic Technique SOP for AMD – V 2.0

Standard Operating Procedure for Aseptic Technique in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/133/2025
Supersedes SOP/AMD/133/2022
Page No. Page 1 of 14
Issue Date 19/05/2025
Effective Date 20/05/2025
Review Date 19/05/2026

1. Purpose

This SOP outlines aseptic techniques to be followed during sample handling, testing, and media preparation within the Analytical Method Development (AMD) laboratory, to prevent contamination and maintain data integrity during microbiological analysis.

2. Scope

This SOP

applies to all AMD personnel involved in microbiological testing procedures such as sterility testing, microbial limit testing, environmental monitoring, and preservative efficacy studies conducted under aseptic conditions.

3. Responsibilities

  • Microbiologist: Implements aseptic technique in all sample handling and testing steps, ensures regular sanitization of the LAF, and maintains logs.
  • Analytical Scientist: Ensures compliance during transfers of materials and samples into aseptic areas.
  • QA Officer: Conducts periodic audits to verify adherence to aseptic practices and evaluates training records.
  • Head – AMD: Approves aseptic protocols and ensures training, qualification, and documentation.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring aseptic technique implementation, periodic retraining, and maintenance of a contamination-free testing environment.

5. Procedure

5.1 Personal Hygiene and Gowning

  1. Personnel must be free from contagious illness or skin infections.
  2. Perform hand washing with antimicrobial soap followed by drying with sterile towels.
  3. Wear sterile gown, gloves, face mask, cap, and shoe covers in the designated gowning area.
  4. Disinfect gloves using 70% IPA before entering the LAF.

5.2 Area Preparation

  1. Switch on the LAF 30 minutes prior to use and verify airflow with an anemometer if required.
  2. Wipe all interior surfaces with sterile 70% IPA or appropriate disinfectant.
  3. Place UV lamp ‘ON’ for 15–30 minutes if applicable, and turn off before work begins.
  4. Ensure that all required materials (media, pipettes, tubes) are sterilized and placed aseptically in the LAF.
  5. Record cleaning activities in Annexure-1: Aseptic Area Preparation Log.

5.3 Handling of Samples and Materials

  1. Minimize movement within and around the LAF during operation to avoid air turbulence.
  2. Disinfect external surfaces of containers and materials with 70% IPA before placing inside LAF.
  3. Work at least 6 inches inside the LAF to avoid external air disturbance.
  4. Use sterile forceps and avoid touching critical parts of sterile equipment (e.g., pipette tips, tube openings).

5.4 Aseptic Techniques During Testing

  1. Do not talk, cough, or sneeze inside the LAF. Avoid rapid hand movements.
  2. Flame sterilize tools like inoculating loops using spirit lamps or Bunsen burners.
  3. Cap and uncap sample containers one at a time. Do not leave containers open unnecessarily.
  4. Perform all microbial transfers using sterile pipettes or micropipettors with barrier tips.
  5. Document each aseptic test activity in Annexure-2: Test Execution Log.

5.5 Post-Testing Activities

  1. Dispose of all used material in designated autoclave or biohazard bags.
  2. Disinfect LAF interior with 70% IPA and allow it to run for 15 minutes post-use.
  3. Update LAF usage log with date, time, analyst name, and activity performed.

5.6 Qualification and Training

  1. Personnel must undergo initial aseptic technique training and annual retraining.
  2. Evaluate practical skills using media fill simulation or growth media handling challenge tests.
  3. Maintain training records in Annexure-3: Personnel Qualification Log.

6. Abbreviations

  • LAF: Laminar Airflow
  • IPA: Isopropyl Alcohol
  • GMP: Good Manufacturing Practice
  • GLP: Good Laboratory Practice
  • SOP: Standard Operating Procedure

7. Documents

  1. Aseptic Area Preparation Log – Annexure-1
  2. Test Execution Log – Annexure-2
  3. Personnel Qualification Log – Annexure-3

8. References

  • USP <797> – Pharmaceutical Compounding—Sterile Preparations
  • EU GMP Annex 1 – Manufacture of Sterile Medicinal Products
  • WHO Guidelines on Good Manufacturing Practices

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Aseptic Area Preparation Log

Date LAF ID Disinfectant Used Sanitized By Remarks
18/05/2025 LAF-002 IPA 70% Rajesh Kumar Cleaned & Ready

Annexure-2: Test Execution Log

Date Sample ID Test Performed Analyst Remarks
19/05/2025 MLT/25/101 Microbial Limit Test Sunita Reddy Completed

Annexure-3: Personnel Qualification Log

Name Date Trained Trainer Evaluation Method Status
Ajay Verma 10/04/2025 QA Trainer Media Fill Qualified

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Expanded aseptic gowning and LAF validation protocol Annual GMP Review
Exit mobile version